feed,title,long_url,short_url
MedRxiv,"A Phase II Study Integrating a Single-Blind Safety Phase with a Double-Blind, Placebo-Controlled Randomized Phase, Assessing Single-Dose Intramuscular or Intranasal Administration to Evaluate the Safety and Immunogenicity of the Recombinant Vaccine Against COVID-19 (AVX/COVID-12 ""Patria"") Based on an Active Newcastle Disease Viral Vector as a Heterologous Booster in Subjects with Evidence of Previous Immunity to SARS-CoV-2",https://medrxiv.org/cgi/content/short/2024.02.11.24302594v1?rss=1,https://da.gd/yAqg3d
